Spent a few hours researching this, this AM. It is more twisted than I realized. But it will give you all a bigger picture. Hang on for the ride!!!!!!!!!!!!—-
In 2001 there was on factory that made the vaccine, called Bioport.The vaccine was approved the FDA, but the (new) machinery to make it was not. In come the lobbyists…
Bioport supplied over 500,000 vaccines to the troops during the Gulf War, there were a small fraction of them that suffered side effects. One death is attributed to the vaccine, and that case is still in the courts.
Biocorp started as a small lab started by the state of Michigan, the lab was then sold to bioport in 1998. This vaccine was a series of 6 shots over an 18 month period, with an annual booster after that.
BioPort was founded in 1998 by Ibrahim El-Hibri, a Lebanese financier. Along with Fuad, his U.S.-educated son, El-Hibri formed BioPort by purchasing vaccine-making facilities of the state of Michigan for $24.75 million. The company’s only product was the anthrax vaccine, called BioThrax, which it sold chiefly to the U.S. military. In mid-2004, the company reorganized as Emergent BioSolutions.
Bruce Ivins worked at the ARMY”S biological warfare lab for 35 years, his job was to develop vaccines and cures for anthrax. The Army let a known homicidal maniac, a person who his therapist all of a sudden claims he is a “revenge” killer work at in a high security lab like that for 35 YEARS?? He worked at the lab until July 10 2008.
The FBI’s suggests Ivins motive for the anthrax mailing is that he wanted human test subjects to test his vaccine on.
Immediately after the anthrax mailings, Ivins allegedly started testing anthrax spores in unauthorized areas outside the main lab. They caught him doing this, but not removing the anthrax from the lab completely? Those actions did not make him suspicious to the FBI then? No it was Hatfill they went after. Makes no sense to
Ivins developed a vaccine that would work on more than 1 type of anthrax. That made it better than the other vaccine, that would only work with 1 type of anthrax. He was Listed as co-inventor of the vaccine and was going to make a good chunk of change when it was He also developed an additive to exsisting vaccines that that would boost their capabilities against bio-terrorism. That most likely would have earned him millions.
The contract to produce these to vaccines were awarded to VaxGen. Who later lost the contract because they could not fill the governments order on time. VaxGen’s defense against those charges were the government was slow to pay and they would not specify how many vaccines were needed or when. They also had to toss out a large amount of the vaccine because of contamination. Most companies would have just delivered it anyhow. Vaxgen sold the vaccine to Bioport. The termination of the contract meant no one got paid.This is also alluded to as a motive for Ivins. I don’t see that either, as the anthrax mailings were several years BEFORE the contract was issued orcancelled. After that Ivins along with two other colleagues worked with BioPort to get the vaccines made. For their efforts they received the Decoration of Exceptional Civilian Service, the highest honor given to nonmilitary employees of the Defense Department. Not bad for a “homicidal maniac” a “sociopath” a “revenge killer”.After losing the contract Vaxgen almost goes broke.Its chief competitor for the contract, buys the vaccine, Bioport,now named Emergent. Who now has labs in Maryland instaed of Michigan,
It cost VaxGen 175 million, to get the vaccine ready, they sold it for 2 million, a percentage of sales. Bioport/Emergent have lobbied heavily in DC, even the WH to get this contract. They now have it at the expense of VioGen. When VaxGen received the contract, Emergent sent no fewer than 50 lobbyists to Dc, some former aides to Cheney. Even though top government scientist supported VaxGen to continue working on the vaccine, lawmakers abruptly ended their contract and turned it over to Emergent.
During this time Vaxgen spent $720,000 on lobbyists
Emergent $1.41 mill, they threatened to stop making the only vaccine currently available, unless they got the contract to make the new vaccine. The government never paid VaxGen for any work done on the vaccine after Emergents lobbyists went to Washington.Placing VaxGen in a dire financial situation.
So only one person owns all the companies that manufacturres the Anthrax vaccine. He went through hoops to get it, even becoming a citizen of the USA. In order to make the vaccine, you need to have the Anthrax, they did. habri also sold anthrax to the Saudi government, after the Us government refused. He is an associate of the Bin Laden family and the Bush family.
Who would profit from the mailing of anthrax? Since the mailing the government has significantly increased it stockpiles of the vaccine. before the mailing the vaccine was sold at about 4.50 a dose. Afterwards it was sold for about $10.00 a dose. When the threat of a new and better vaccine was about to hit the market, that company was sabotaged and had its contract dropped abruptly.
Backdrop this against the patriot act that demolished civil liberties was being debated on in congress and in the senate. It was not looking good for passage unless some major changes were made. Then anthrax hit the hill and it passed as is.
http://www.msnbc.msn.com/id/3067486/
http://ap.google.com/article/ALeqM5gH1f … QD929R1O80
http://www.latimes.com/news/printeditio … 8967.story
The UK’s Health Protection Agency manufactures another anthrax vaccine at its facilities in Porton Down.
http://news.bbc.co.uk/2/hi/health/3652385.stm
Lawsuits associated with the claims Vaxgen made about the vaccine:
http://www.lawyersandsettlements.com/ca … fraud.html
http://articles.latimes.com/2007/jan/06 … fi-vaxgen6
http://www.fiercebiotech.com/story/stru … 2008-05-05
http://www.latimes.com/news/nationworld … full.story
Bin Laden Profits from US Anthrax Vaccine Manufacture?
By Ian Gurney.
Author of “The Cassandra Prophecy.”
www.caspro.com
It’s a story straight off the pages of a John Le Carre or Robet Ludlum thriller. A mysterious Lebanese millionaire, who already owns telecoms companies in Venezuela and El Salvador, uses his influence to take over the sole manufacture, production and distribution of one of Americas most sought after defence products. Meanwhile, the world’s most wanted terrorist appears to be profiting from his family’s investment in the self same manufacturing process, assisted by no less a personage than the father of the President of the United States. Sounds fanciful?
Well, on December 1st. last year the Pakistan News Service announced that documents belonging to a United States company called BioPort Corporation were found in the possession of the al-Qaeda in Kabul, Afghanistan. Seven weeks later, on January 16th, the United States Food and Drug Administration, which had, since 1999 prohibited BioPort from manufacture and production at its Michigan laboratories, announced that it had given its conditional approval for BioPort to begin the manufacture, production and shipping of its product to the US military. On February 1st. the US government gave BioPort Corp a green light on to resume production that had been shut down by the Food and Drug Administration for three years.
So, exactly what is BioPort, what do they produce and who runs the company? Well, BioPort, based in North Lansing, Michigan, is the only corporation in the United States with a license to make the Anthrax vaccine. Except that BioPort doesn’t actually make the vaccine, BioPort simply bought the laboratory that does make the vaccine, Michigan Biologic Products Institute, from the State of Michigan in 1998.
Less than a month after it took over the business, BioPort acquired Michigan Biologic Products Institute’s sole and exclusive customer for the Anthrax vaccine, the US Department of Defence, and an exclusive $29 million contract with the Department of Defence to “manufacture, test, bottle and store the anthrax vaccine.” The Pentagon agreed to pay BioPort $4.70 per shot and each member of the armed forces, that’s 2.4 million soldiers, sailors, airmen and Marines, is supposed to get six shots over an 18-month period. That’s a huge, guaranteed market for BioPort’s product. Indeed, according to former Central Intelligence Agency military analyst Patrick Eddington, the estimated $60 million worth of anthrax vaccine BioPort is expected to produce for the Defence Department over the next five years could just be the beginning.
“The Pentagon has a $322 million, 10-year programme to develop at least three, and perhaps as many as a dozen additional biological warfare vaccines, making BioPort a huge profit.” Eddington told ABCNews. However, since acquiring Michigan Biologic Products Institute, BioPort has only delivered a small amount of the anthrax vaccine to the US Defence Department. In fact, just 4% of the vaccine contracted for has so far been delivered because Food and Drug Administration audits uncovered suspicious record keeping as well as security and contamination problems at BioPort’s laboratories, causing the FDA to ban delivery of the product until a few days ago.
So now lets look at who owns and runs BioPort Corporation. Let’s begin with Admiral William J. Crowe Jr. former Head of the US Joint Chiefs of Staff and a former US ambassador to Great Britain. It seems that back when President George H. W. Bush was setting up Osama Bin Laden as a “freedom fighter” (Afghanistan’s “freedom fighters” were credited with shooting down more than 270 Soviet aircraft using American made Stinger missiles in the 1980’s) the good Admiral and his associates on the Joint Chiefs of Staff were, according to some reports, selling American made weapons-grade Anthrax to Saddam Hussein in the hopes that he would use it against Iran. These days Admiral Crowe sits on the Board of Directors and owns 13% of BioPort Corp.
According to ABC News reporter Howard L. Rosenberg: “BioPort Corp. was created solely to take over the assets of Michigan Biologic Products Institute by Admiral Crowe, his partners in a company called Intervac L.L.C. and a group of former managers of the Michigan-based institute.”
It is Intervac that has the most interesting history here. According to Crowe’s associate and spokesman, Jay Coupe, Crowe owns 22.5 percent of Intervac shares, although he hasn’t “invested a penny” in the venture. Another 30 percent of Intervac shares are owned by Nancy El-Hibri, a mother and homemaker in suburban Maryland and the rest of the company is in the hands of “I&F Holdings,” a company directed by Nancy El-Hibri’s father-in-law, Ibrahim El-Hibri, a Venezuelan citizen, and her husband, Fuad El-Hibri, a German citizen of Lebanese descent. According to Coupe, when Crowe returned from England in 1997, he was approached by Fuad El-Hibri’s father, Ibrahim El-Hibri. The elder El-Hibri, whom the admiral had met a decade before, invited Crowe to serve on the board of Intervac.
Fuad El-Hibri appears to be the real day-to-day director of Intervac and is listed by Dun & Bradstreet as the “chief executive” of Bioport. The reclusive Ibrahim El Hibri, who grants no interviews, has homes in Caracas, Maryland, Paris and Beirut, which he visits all year around, being careful of avoiding tax residence in any of them. Where he got his millions is a mystery. He invested in Porton International, a British pharmaceutical firm where his son worked, in the early 90’s and according to a US Congressional review, Porton International sold anthrax vaccines to the Saudi Arabian Government. In Venezuela, Ibrahim El Hibri runs the country’s third largest cell phone operator Digitel, despite having sold control of the company to Telecom Italia Mobile. Meanwhile in El Salvador, his son Fuad El Hibri, finds the time to run Digicel, a cellular telephone concession which the family bought two years ago.
After the attacks of September 11th. President Bush placed BioPort’s North Lansing laboratory under protection, invoking the national interest. Interestingly enough, the Italian magazine Il Manifesto reported, in its October issue, that this happened at the same time that the FBI also placed the El Hibri’s at the top of their list of suspects for sending anthrax spores through the mail system.
So, it seems that Admiral Crowe, the El-Hibris and their fellow investors in BioPort are set to make a nice profit from the Anthrax scare. And who are those fellow investors? Reports in the US media, denied by BioPort, have suggested that one major investor in the company is the Carlyle Group, one of America’s most successful investment companies, well known for generating “extraordinary returns” for its customers through investments in the US defence industry. Because the Carlyle Group remains privately held, it is not required to disclose details of its investments or business activities, it has, however, an impressive array of board members. Former President George Bush Sr. and former UK Prime Minister John Major are directors of The Carlyle Group, as are other top US Republicans including former Secretary of State James A. Baker, and former Defence Secretary and deputy CIA Director Frank Carlucci.
Now comes the interesting part of this story. According to reports in the US media, until October last year a major investor with The Carlyle Group was (and you had better sit down before you read this) the bin Laden family! For many years The Carlyle Group has maintained financial ties with the family of Osama bin Laden, but those links were supposedly severed after September 11th. when it was agreed that the relationship was becoming a tad embarrassing for all concerned.
The story behind the Carlyle Group and the links between George Bush Sr. and the bin Ladens is fascinating to say the least.
In the 1970’s, Salem Bin Laden, the eldest of Osama Bin Laden’s 55 brothers and sisters, invested heavily in George H. W. Bush’s first business venture, Arbusto Energy. Salem became Bush’s business partner through James Bath, a close friend of the future American president. Salem appointed Bath as his representative in Houston, Texas. It was Bath who invested $50,000 in Bush’s company Arbusto and also bought Houston Gulf Airport on behalf of Osama’s elder brother. Since then business links between Bush Sr. and the Bin Laden family have flourished, particularly since Bush Sr. joined the Carlyle Group. On September 27th. last year The Wall Street Journal reported that:
“George H.W. Bush, the father of President Bush, works for the bin Laden family business in Saudi Arabia through the Carlyle Group, an international investment consulting firm. The senior Bush has met with the bin Laden family at least twice.
Osama bin Laden has supposedly been “disowned” by his family, which runs the Saudi Bin Laden Group, a multi-billion dollar construction business in Saudi Arabia. However, Osama’s sister-in-law, in a recent interview with America’s ABC News, said that she believed that members of her family still supported Osama bin Laden.
If the rumours are correct about the Carlyle Group’s investment in BioPort, then it’s quite possible the bin Laden family is an investor in the only company able to make Anthrax vaccine in the United States, and because their beloved Osama might have some of the stuff, the family will make a fortune. In fact, the shortage of vaccine created by the now withdrawn FDA ban will make all those involved in BioPort extremely wealthy, as market forces drive the price of the vaccine up. A very cosy arrangement. The Bushes, El Hibri’s and bin Ladens (and the occasional complicit Admiral) could all be making money off the fear and death of Americans. Is it any wonder, then, that documents relating to BioPort were found in the possession of bin Laden’s al-Qaeda network in Kabul?
http://whatreallyhappened.com/WRHARTICLES/binladenprofits.html?q=binladenprofits.html
There is also more connections to Habri, like Hamilton (of the Lee, Hamilton, baker report) and their banking connections. But I have spent enough time on just these connections.
Ibrahim El-Hibri
Fuad El-Hibri is Chairman and CEO of the Bioport Corporation and son of Ibrahim El-Hibri. According to the corporation’s web site, El-Hibri “served as a director and a member of the senior management team of Speywood Holdings Ltd., in the United Kingdom. Mr. El-Hibri has over 10 years of experience in the bio-pharmaceutical industry.”[1]
In his June 30, 1999, testimony before “The Subcommittee on National Security, Veterans Affairs, and International Relations of the House Committee on Government Reform,” El-Hibri stated that:[2]
“Three companies currently hold voting equity in BioPort: Intervac LLC and Intervac Management LLC, which are both Maryland limited liability companies, and Michigan Biologic Products, Inc., a Michigan corporation. Intervac LLC is the controlling shareholder. Intervac LLC is owned by Admiral William J. Crowe, Jr., my wife Nancy and me, and I and F Holdings N.V., a Netherlands Antilles investment company owned by my father Ibrahim El-Hibri. As mentioned earlier, I and F Holdings is an investment company in biotech operations, which previously had invested in the management buy-out of Porton Products Ltd. Admiral Crowe and I are the controlling members of Intervac LLC.”
Suber says that, “While Fuad El-Hibri was [sic] needed no financing to take over the State of Michigan biologic lab, he did need a front man to reassure the military with respect to their Anthrax contract. He already had the perfect front man in former chairman of the Joint Chiefs of Staff, Adm. William J. Crowe Jr. Adm. Crowe had a long history of involvement with the El-Hibri family. Crowe owns 22.5 percent of Intervac shares, although he hasn’t invested a penny in the venture.”
http://www.sourcewatch.org/index.php?ti … d_El-Hibri
this is scary folks….
El-Hibri, owns Emergent, which bought biocorp. He also owns Porton the UK biodefense firm. also in this witch’s brew… VNeogen Corp., “a Lansing (Michigan) -based food safety research and development company,”. Interestingly, Neogen has not been referenced subsequently in connection with BioPort.
In short, the precise ownership of BioPort is unclear.
http://www.forensic-intelligence.org/Crowe.PDF
Hibri went though hoops to make sure he was owner of the few companies that make bio defense vaccines. Mostly anthrax.